Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000891293-22-000032)

Filing Details

Accession Number:: 0000891293-22-000032
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-16 16:19:11
Reporting Period:: 2022-06-14

Accepted Time:: 2022-06-16 16:19:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891293	Cti Biopharma Corp	CTIC	Pharmaceutical Preparations (2834)	911533912

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276750	David Kirske	C/O Cti Biopharma Corp. 3101 Western Ave., Suite 800 Seattle WA 98121	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-06-14	10,000	$0.95	17,397	No	4	M	Direct
Common Stock	Disposition	2022-06-14	10,000	$5.50	7,397	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2022-06-14	10,000	$0.00	10,000	$0.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
490,000		2029-02-19	No	4	M	Direct

Footnotes

This sale was effected pursuant to a 10b5-1 sales plan adopted by the reporting person.
One third of the shares underlying the option vested on 2/19/2020 and annually thereafter until all the underlying shares were fully vested on 2/19/2022.